Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatment

BACKGROUND: The emergence of immune checkpoint inhibitors has changed the landscape of first-line treatment of patients with advanced gastric cancer. Currently, the prognostic significance of inflammatory markers in first-line immunotherapy combined with chemotherapy for gastric cancer is currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Mingyu, Ding, Yongfeng, Mao, Chenyu, Ma, Xiaolu, Li, Ning, Xiao, Cheng, Qian, Jiong, Jiang, Haiping, Zheng, Yulong, Wu, Luntao, Teng, Lisong, Xu, Nong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650180/
https://www.ncbi.nlm.nih.gov/pubmed/36387183
http://dx.doi.org/10.3389/fonc.2022.1029960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650180/
https://www.ncbi.nlm.nih.gov/pubmed/36387183
http://dx.doi.org/10.3389/fonc.2022.1029960

Ejemplares similares